Evidence map›Paper›PMID 35450475›Full record

SynthesisInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2023

Endovascular Thrombectomy With or Without Intravenous Thrombolysis: A Meta-Analysis of Randomized Controlled Trials.

Muhammad F Ishfaq, Sana Gulraiz, Wei Huang, Iryna Lobanova, Renee H Martin, Brandi R French, Farhan Siddiq, Erdem Gurkas, Emrah Aytac, Camilo R Gomez and 1 more

Abstract readMeta-AnalysisReview
In one paragraph

Synthesis in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Muhammad F IshfaqZeenat Qureshi Stroke Institute, St Cloud, MN.ORCID 0000-0003-2336-8230
Sana GulraizZeenat Qureshi Stroke Institute, St Cloud, MN.
Wei HuangZeenat Qureshi Stroke Institute, St Cloud, MN.
Iryna LobanovaZeenat Qureshi Stroke Institute, St Cloud, MN.
Renee H MartinDepartment of Public Health Sciences, Medical University of South Carolina, SC, USA.
Brandi R FrenchDepartment of Neurology, 2628University of Missouri, MO, USA.
Farhan SiddiqDivision of Neurosurgery, University of Missouri, Columbia. MO.
Erdem GurkasZeenat Qureshi Stroke Institute, St Cloud, MN.
Emrah AytacZeenat Qureshi Stroke Institute, St Cloud, MN.ORCID 0000-0001-8404-7049
Camilo R GomezDepartment of Neurology, 2628University of Missouri, MO, USA.
Adnan I QureshiZeenat Qureshi Stroke Institute, St Cloud, MN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe performed this meta-analysis of randomized clinical trials to compare the outcomes in patients treated with endovascular thrombectomy who receive prior intravenous thrombolysis with those who do not receive such treatment. Recently, one randomized trial reported outcomes to address this issue, so timely update of meta-analysis is needed to determine the value of administering intravenous thrombolysis before endovascular thrombectomy. MATERIALS AND

methodsFour randomized clinical trials are included in our meta-analysis. We calculated pooled odds ratios and 95% CIs using random-effects models. The primary efficacy endpoint was a favorable outcome defined by a modified Rankin Scale score of 0 (no symptoms), 1 (no significant disability), or 2 (slight disability) at 90 days post-randomization. Secondary endpoints analyzed were any intracerebral hemorrhage, symptomatic intracerebral hemorrhage, and mortality.

resultsOf the 1633 patients randomized, the proportion of patients who achieved a favorable outcome was similar between endovascular thrombectomy alone and combined approach with intravenous thrombolysis and endovascular thrombectomy (1631 patients analyzed; odds ratio 1.02; CI 0.84-1.25; p = 0.83). Risk of any intracerebral hemorrhage was significantly lower among those randomized to endovascular thrombectomy alone (1633 patients analyzed; odds ratio 0.75; CI 0.57-0.99; p = 0.04). Rates of symptomatic intracerebral hemorrhage (p = 0.36) and mortality (p = 0.62) were not significantly different between the two groups.

conclusionsCompared with endovascular thrombectomy preceded by intravenous thrombolysis, endovascular thrombectomy resulted in similar rates of favorable outcome with a lower rate of intracerebral hemorrhage. A large phase 3 trial is required to conclusively demonstrate equivalency of both approaches to guide future practice.

Indexed as

Brain IschemiaEndovascular ProceduresStrokeCerebral HemorrhageFibrinolytic AgentsHumansRandomized Controlled Trials as TopicThrombectomyThrombolytic TherapyTreatment OutcomeFibrinolytic AgentsInterventionstrokethrombectomythrombolysis

Identifiers

PMID35450475
PMCPMC10152830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.